172 related articles for article (PubMed ID: 26674359)
1. Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection.
Varchetta S; Mele D; Lombardi A; Oliviero B; Mantovani S; Tinelli C; Spreafico M; Prati D; Ludovisi S; Ferraioli G; Filice C; Aghemo A; Lampertico P; Facchetti F; Bernuzzi F; Invernizzi P; Mondelli MU
Gut; 2016 Dec; 65(12):1998-2006. PubMed ID: 26674359
[TBL] [Abstract][Full Text] [Related]
2. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
[TBL] [Abstract][Full Text] [Related]
3. Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication.
Zhao D; Jiang X; Xu Y; Yang H; Gao D; Li X; Gao L; Ma C; Liang X
Front Immunol; 2018; 9():1124. PubMed ID: 29899741
[TBL] [Abstract][Full Text] [Related]
4. [Reduced frequency of natural killer cell on siglec-7(+) is associated with progression of hepatitis B virus-related cirrhosis].
Li YL; Zhang QF; Yin WW; Zhang DZ
Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):420-425. PubMed ID: 30317754
[No Abstract] [Full Text] [Related]
5. Increased Frequency of Dysfunctional Siglec-7
Sakamoto Y; Yoshio S; Doi H; Mori T; Matsuda M; Kawai H; Shimagaki T; Yoshikawa S; Aoki Y; Osawa Y; Yoshida Y; Arai T; Itokawa N; Atsukawa M; Ito T; Honda T; Mise Y; Ono Y; Takahashi Y; Saiura A; Taketomi A; Kanto T
Front Immunol; 2021; 12():603133. PubMed ID: 33692781
[TBL] [Abstract][Full Text] [Related]
6. Immunological changes in different patient populations with chronic hepatitis C virus infection.
Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
[TBL] [Abstract][Full Text] [Related]
8. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
[TBL] [Abstract][Full Text] [Related]
9. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.
Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J
J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286
[TBL] [Abstract][Full Text] [Related]
10. Siglec-7 Defines a Highly Functional Natural Killer Cell Subset and Inhibits Cell-Mediated Activities.
Shao JY; Yin WW; Zhang QF; Liu Q; Peng ML; Hu HD; Hu P; Ren H; Zhang DZ
Scand J Immunol; 2016 Sep; 84(3):182-90. PubMed ID: 27312286
[TBL] [Abstract][Full Text] [Related]
11. Functions of liver natural killer cells are dependent on the severity of liver inflammation and fibrosis in chronic hepatitis C.
Fugier E; Marche H; Thélu MA; Macek Jílková Z; Van Campenhout N; Dufeu-Duchesne T; Leroy V; Zarski JP; Sturm N; Marche PN; Jouvin-Marche E
PLoS One; 2014; 9(4):e95614. PubMed ID: 24759660
[TBL] [Abstract][Full Text] [Related]
12. NKp30 isoforms in patients with chronic hepatitis C virus infection.
Mantovani S; Mele D; Oliviero B; Barbarini G; Varchetta S; Mondelli MU
Immunology; 2015 Oct; 146(2):234-42. PubMed ID: 26094914
[TBL] [Abstract][Full Text] [Related]
13. [Alteration of CD100 expression on natural killer cells in chronic patients with hepatitis C virus before and after initiation of antiviral treatment].
He Y; Li B; Zhou Y; Zhang Y; Guo Y; Ji G; Fan C; Jia Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):856-60. PubMed ID: 25108441
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.
Ahlenstiel G; Titerence RH; Koh C; Edlich B; Feld JJ; Rotman Y; Ghany MG; Hoofnagle JH; Liang TJ; Heller T; Rehermann B
Gastroenterology; 2010 Jan; 138(1):325-35.e1-2. PubMed ID: 19747917
[TBL] [Abstract][Full Text] [Related]
15. The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment.
Pembroke T; Christian A; Jones E; Hills RK; Wang EC; Gallimore AM; Godkin A
Gut; 2014 Mar; 63(3):515-24. PubMed ID: 23665989
[TBL] [Abstract][Full Text] [Related]
16. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
[TBL] [Abstract][Full Text] [Related]
17. Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.
Bhardwaj S; Ahmad F; Wedemeyer H; Cornberg M; Schulze Zur Wiesch J; van Lunzen J; Sarin SK; Schmidt RE; Meyer-Olson D
Virol J; 2016 Apr; 13():67. PubMed ID: 27091211
[TBL] [Abstract][Full Text] [Related]
18. Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection.
Varchetta S; Mele D; Mantovani S; Oliviero B; Cremonesi E; Ludovisi S; Michelone G; Alessiani M; Rosati R; Montorsi M; Mondelli MU
Hepatology; 2012 Sep; 56(3):841-9. PubMed ID: 22431186
[TBL] [Abstract][Full Text] [Related]
19. Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology.
Lund Laursen T; Brøckner Siggard C; Kazankov K; Damgaard Sandahl T; Møller HJ; Ong A; Douglas MW; George J; Tarp B; Hagelskjaer Kristensen L; Lund Laursen A; Hiramatsu A; Nakahara T; Chayama K; Grønbaek H
Scand J Gastroenterol; 2018 Aug; 53(8):986-993. PubMed ID: 29987961
[TBL] [Abstract][Full Text] [Related]
20. Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
Saini P; Adeniji OS; Bordoloi D; Kinslow J; Martinson J; Parent DM; Hong KY; Koshy J; Kulkarni AJ; Zilberstein NF; Balk RA; Moy JN; Giron LB; Tracy RP; Keshavarzian A; Muthumani K; Landay A; Weiner DB; Abdel-Mohsen M
mBio; 2023 Feb; 14(1):e0339322. PubMed ID: 36728420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
